Literature DB >> 20236357

Chemokine CCL3 facilitates the migration of hepatoma cells by changing the concentration intracellular Ca.

Yufeng Yuan1, Jun Liu, Zhisu Liu, Yueming He, Zhonglin Zhang, Congqing Jiang, Qun Qian.   

Abstract

AIM: Recurrence and metastasis are the major factors associated with the poor prognosis of hepatocellular carcinoma (HCC). It was confirmed that multiple chemokines and their receptors are related to the progression and metastasis of HCC. The aim of this research was to conduct an investigation into whether macrophage inflammatory protein-1alpha/CCL3, and its receptor CCR1 play a role in HCC invasion and metastasis.
METHODS: We used reverse transcription polymerase chain reaction, immunocytochemistry and flow cytometry to detect CCR1 mRNA and protein expression in the four hepatoma cell lines HepG2, Hep3B, HLE and HLF; and we conducted a microscope cell migration experiment to observe the pseudopodia formation and mobility of the hepatoma cells. The concentration of intracellular calcium was measured by fluorescence microscopy.
RESULTS: CCR1 mRNA and protein were positively expressed in the four hepatoma cell lines HepG2, Hep3B, HLE and HLF. Following CCL3 stimulation, obvious pseudopodia formation of hepatoma cells was observed using a fluorescence microscope. The cell migration experiment showed that after incubation with CCL3, the number of Hep3B cells which passed through the polycarbonate microporous filter membranes increased to an obvious extent. After CCL3 incubation, the intracellular Ca(2+) level of the Hep3B cells increased to an obvious extent.
CONCLUSION: Chemokine CCL3 facilitates the migration of hepatoma by changing the concentration intracellular Ca(2+). The CCL3-CCR1 axis may play an important role in HCC invasion and metastasis. It may also be a potential target for HCC therapy or for prevention of the recurrence and metastasis of HCC.

Entities:  

Year:  2010        PMID: 20236357     DOI: 10.1111/j.1872-034X.2009.00619.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  7 in total

Review 1.  Lessons from rare tumors: hepatic lymphoepithelioma-like carcinomas.

Authors:  Antonio Solinas; Diego F Calvisi
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

Review 2.  Chemokines and their receptors play important roles in the development of hepatocellular carcinoma.

Authors:  Chun-Min Liang; Long Chen; Heng Hu; Hui-Ying Ma; Ling-Ling Gao; Jie Qin; Cui-Ping Zhong
Journal:  World J Hepatol       Date:  2015-06-08

3.  CCL3 Promotes Proliferation of Colorectal Cancer Related with TRAF6/NF-κB Molecular Pathway.

Authors:  Xiaoqiang Ma; Jinda Su; Shaohui Zhao; Yaqin He; Shuzhen Li; Xiaoliang Yang; Sifan Zhai; Shikuo Rong; Xin Zhang; Guangxian Xu; Xiaoliang Xie
Journal:  Contrast Media Mol Imaging       Date:  2022-07-12       Impact factor: 3.009

4.  Expression of YKL-40 and MIP-1a proteins in exudates and transudates: biomarkers for differential diagnosis of pleural effusions? A pilot study.

Authors:  Tonia Adamidi; Nikolaos Soulitzis; Eirini Neofytou; Savvas Zannetos; Andreas Georgiou; Kleomenis Benidis; Alexis Papadopoulos; Nikolaos M Siafakas; Sophia E Schiza
Journal:  BMC Pulm Med       Date:  2015-12-01       Impact factor: 3.317

5.  Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High-Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.

Authors:  Ning Xue; Jian-Hua Lin; Shan Xing; Dan Liu; Shi-Bing Li; Yan-Zhen Lai; Xue-Ping Wang; Min-Jie Mao; Qian Zhong; Mu-Sheng Zeng; Wan-Li Liu
Journal:  Cancer Res Treat       Date:  2018-05-29       Impact factor: 4.679

6.  Role of chemokines in hepatocellular carcinoma (Review).

Authors:  Dongdong Xue; Ya Zheng; Junye Wen; Jingzhao Han; Hongfang Tuo; Yifan Liu; Yanhui Peng
Journal:  Oncol Rep       Date:  2020-12-22       Impact factor: 3.906

7.  Relevance of CCL3/CCR5 axis in oral carcinogenesis.

Authors:  Janine Mayra da Silva; Tálita Pollyanna Moreira Dos Santos; Lays Martin Sobral; Celso Martins Queiroz-Junior; Milene Alvarenga Rachid; Amanda E I Proudfoot; Gustavo Pompermaier Garlet; Aline Carvalho Batista; Mauro Martins Teixeira; Andréia Machado Leopoldino; Remo Castro Russo; Tarcília Aparecida Silva
Journal:  Oncotarget       Date:  2017-04-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.